Skip to content

Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics

Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03297853
Enrollment
64
Registered
2017-09-29
Start date
2014-01-01
Completion date
2018-03-30
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesics Grade 2's Addiction

Keywords

Descriptive, Support, Retrospective, survey

Brief summary

The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2. Risk factors of misuse as well as diagnostic tools were identified.

Detailed description

The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2. Risk factors of misuse as well as diagnostic tools were identified. The objectives of our research are to determine the characteristics of the individuals suffering from an addiction to analgesics of level 2 followed in consultation of addictology in the hospital of Montpellier and Nimes and to describe the type of follow-up proposed to the patients in these two centers. It is a retrospective and descriptive study. As part of this research, we will solicit all the patients followed in consultation of addictology or in hospitalization to the hospital of Montpellier or Nîmes for an addiction to the analgesics of grade 2 between the 1st of January 2014 and the 10th of July 2017 with requests of management for withdrawal or reduction of doses, opioid analgesics in the absence of pain or in chronic non-cancer pain, opioid analgesics to avoid withdrawal syndrome or hyperalgesia and consumptions chronic to dosages inadequate to the functional complaint evaluated by the rhumatology or algology services. The data are collected in the medical file at the two participating institutions (Montpellier and Nîmes) and if necessary, patients not seen in consultation for more than 6 months will be recontacted.

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Requests for management for weaning or reduction of doses * Take opioid analgesics in the absence of pain or as part of chronic non-cancer pain * Opioid analgesics to prevent withdrawal syndrome or hyperalgesia * Chronic consumption at inadequate dosages compared to the functional complaint evaluated by the MPR / Algologie services * Patients over 18 years and who agree with the study

Exclusion criteria

* language barrier * severe cognitive and / or psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
50/5000 Prevalence of demand for care in addictology1 dayPrevalence of demand for addictive care in subjects with addiction to analgesics in level 2

Secondary

MeasureTime frameDescription
Types of support proposed1 dayTypes of support proposed
Assessment of analgesic dependence1 dayAssessment of analgesic dependence
History of analgesic use1 dayHistory of analgesic use
quality of life1 dayquality of life

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026